The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dulkys, Y.
Right arrow Articles by Elsner, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dulkys, Y.
Right arrow Articles by Elsner, J.
The Journal of Immunology, 2001, 167: 3443-3453.
Copyright © 2001 by The American Association of Immunologists

IL-3 Induces Down-Regulation of CCR3 Protein and mRNA in Human Eosinophils1

Yasmin Dulkys*, Christof Kluthe*, Thomas Buschermöhle*, Ines Barg*, Sabine Knöß*, Alexander Kapp*, Amanda E. I. Proudfoot{dagger} and Jörn Elsner2

* Department of Dermatology and Allergology, Hannover Medical University, Hannover, Germany; and {dagger} Serono Pharmaceutical Research Institute, Geneva, Switzerland

Cytokines and chemokines are responsible for the attraction and activation of eosinophils in allergic and inflammatory diseases. Whereas cytokines such as IL-3, IL-5, and GM-CSF activate eosinophils via heterodimeric receptors containing a distinct {alpha}-chain (binding domain) and a common {beta}-chain (signaling domain), chemokines such as eotaxin activate eosinophils via seven-transmembrane Gi protein-coupled CCRs. Recent studies have demonstrated the importance of CCR3 on human eosinophils that undergo receptor recycling after chemokine activation, but the modulation of this receptor by cytokines has not yet been addressed. In this study, we demonstrate that IL-3 induces a dose- and time-dependent down-regulation of CCR3 from the surface of human eosinophils comparable to the CCR3-specific ligand eotaxin, whereas IL-5, GM-CSF, IL-4, IL-10, IL-13, IFN-{gamma}, and TNF-{alpha} had no effect. Maximal down-regulation of CCR3 in response to IL-3 was reached at 24 h. Reduction of CCR3 surface protein in response to IL-3 could be prevented by an anti-IL-3 mAb and was neither due to the release of CC chemokines nor to nonspecific binding of IL-3 to CCR3. Moreover, down-regulation was prevented by phenylarsine oxide, a nonspecific inhibitor of receptor internalization. After 24 h, IL-3-induced decrease of CCR3 surface expression correlated with diminished mRNA expression, suggesting a transcriptional regulation mechanism. Since wortmannin partially inhibited IL-3- but not eotaxin-induced CCR3 down-regulation, receptor down-modulation seems to underlie different signaling events. Therefore, these data suggest a novel role for the cytokine IL-3 in the activation process of eosinophils and its predominant chemokine receptor CCR3.




This article has been cited by other articles:


Home page
J. Immunol.Home page
U. Forssmann, C. Stoetzer, M. Stephan, C. Kruschinski, T. Skripuletz, J. Schade, A. Schmiedl, R. Pabst, L. Wagner, T. Hoffmann, et al.
Inhibition of CD26/Dipeptidyl Peptidase IV Enhances CCL11/Eotaxin-Mediated Recruitment of Eosinophils In Vivo
J. Immunol., July 15, 2008; 181(2): 1120 - 1127.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
S. Gupta, B. Fuchs, S. Schulz-Maronde, A. Heitland, S. E. Escher, M. Mack, H.-C. Tillmann, A. Braun, W.-G. Forssmann, J. Elsner, et al.
Intravascular inactivation of CCR5 by n-Nonanoyl-CC chemokine ligand 14 and inhibition of allergic airway inflammation
J. Leukoc. Biol., March 1, 2008; 83(3): 765 - 773.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. Munitz, I. Bachelet, R. Eliashar, M. Khodoun, F. D. Finkelman, M. E. Rothenberg, and F. Levi-Schaffer
CD48 Is an Allergen and IL-3-Induced Activation Molecule on Eosinophils
J. Immunol., July 1, 2006; 177(1): 77 - 83.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
S. Gupta, S. Schulz-Maronde, C. Kutzleb, R. Richter, W.-G. Forssmann, A. Kapp, U. Forssmann, and J. Elsner
Cloning, expression, and functional characterization of cynomolgus monkey (Macaca fascicularis) CC chemokine receptor 1
J. Leukoc. Biol., November 1, 2005; 78(5): 1175 - 1184.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
U. Forssmann, I. Hartung, R. Balder, B. Fuchs, S. E. Escher, N. Spodsberg, Y. Dulkys, M. Walden, A. Heitland, A. Braun, et al.
n-Nonanoyl-CC Chemokine Ligand 14, a Potent CC Chemokine Ligand 14 Analogue That Prevents the Recruitment of Eosinophils in Allergic Airway Inflammation
J. Immunol., September 1, 2004; 173(5): 3456 - 3466.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
V. J. Erpenbeck, A. Hagenberg, Y. Dulkys, J. Elsner, R. Balder, H. Krentel, M. Discher, A. Braun, N. Krug, and J. M. Hohlfeld
Natural Porcine Surfactant Augments Airway Inflammation after Allergen Challenge in Patients with Asthma
Am. J. Respir. Crit. Care Med., March 1, 2004; 169(5): 578 - 586.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
Z. Qiuping, L. Qun, H. Chunsong, Z. Xiaolian, H. Baojun, Y. Mingzhen, L. Chengming, H. Jinshen, G. Qingping, Z. Kejian, et al.
Selectively Increased Expression and Functions of Chemokine Receptor CCR9 on CD4+ T Cells from Patients with T-Cell Lineage Acute Lymphocytic Leukemia
Cancer Res., October 1, 2003; 63(19): 6469 - 6477.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
B. Gregory, A. Kirchem, S. Phipps, P. Gevaert, C. Pridgeon, S. M. Rankin, and D. S. Robinson
Differential Regulation of Human Eosinophil IL-3, IL-5, and GM-CSF Receptor {alpha}-Chain Expression by Cytokines: IL-3, IL-5, and GM-CSF Down-Regulate IL-5 Receptor {alpha} Expression with Loss of IL-5 Responsiveness, but Up-Regulate IL-3 Receptor {alpha} Expression
J. Immunol., June 1, 2003; 170(11): 5359 - 5366.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2001 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2001 by The American Association of Immunologists, Inc. All rights reserved.